CYN vs DGX · rev $249.0K vs P/E 22, rev $5.94B
Cyngn Inc (CYN) versus Quest Diagnostics Incorporated (DGX) — a side-by-side from cached financials, not a winner call.
Cyngn Inc (CYN) is a software - application company listed on US.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Latest reported CYN revenue for 2026-06-30 was $249.0K. Net income was -$12.8M. CYN currently screens at market cap $23.8M.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
CYN currently screens at market cap $23.8M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Not investment advice. Open the CYN and DGX stock pages for the full models.
Not investment advice.